CD200 and Parkinson disease: Evidence for the involvement of MRC in the pathogenesis of PD emerged in the early 1980s with reports of Parkinsonian-like presentation of intravenous users of the synthetic drug, 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP), which was also known as synthetic heroin [43].